{"url_path":"/sec/dtil/8-k/2026-07-01/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1357874/0001628280-26-046340-index.html","accession_number":"0001628280-26-046340","cik":"0001357874","ticker":"DTIL","issuer_name":"PRECISION BIOSCIENCES INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1357874/0001628280-26-046340-index.html","primary_entity_key":"0001357874","primary_entity_name":"PRECISION BIOSCIENCES INC"},"word_count":131,"has_tables":true,"body_markdown":"Item 7.01 Regulation FD Disclosure.\n\nPrecision BioSciences, Inc. (the “Company”) has updated its corporate deck, which is available in the “Investors” portion of the Company’s website at https://investor.precisionbiosciences.com.\n\nPursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, this Item 7.01 of this Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any registration statement or other filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing."}